At the time of writing, Chimerix Inc [CMRX] stock is trading at $1.06, up 4.95%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CMRX shares have gain 10.88% over the last week, with a monthly amount drifted -14.52%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 21, March 2024, Chimerix Appoints Marc D. Kozin to Board of Directors. In a post published today on Yahoo Finance, Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy Experience.
From an analyst’s perspective:
Chimerix Inc [NASDAQ: CMRX] stock has seen the most recent analyst activity on May 23, 2023, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $7. Previously, CapitalOne started tracking the stock with Overweight rating on September 07, 2022, and set its price target to $7. On April 29, 2021, Maxim Group initiated with a Buy rating and assigned a price target of $20 on the stock. Wedbush initiated its recommendation with a Outperform and recommended $21 as its price target on March 31, 2021. Jefferies started tracking with a Buy rating for this stock on March 31, 2021, and assigned it a price target of $21. In a note dated February 14, 2018, JP Morgan downgraded an Underweight rating on this stock.
For the past year, the stock price of Chimerix Inc fluctuated between $0.88 and $1.57. Chimerix Inc [NASDAQ: CMRX] shares were valued at $1.06 at the most recent close of the market.
Analyzing the CMRX fundamentals
According to Chimerix Inc [NASDAQ:CMRX], the company’s sales were 0.32M for trailing twelve months, which represents an -99.51% plunge. Gross Profit Margin for this corporation currently stands at -51.25% with Operating Profit Margin at -287.24%, Pretax Profit Margin comes in at -253.38%, and Net Profit Margin reading is -244.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.37 and Total Capital is -0.48. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0133 points at the first support level, and at 0.9667 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0983, and for the 2nd resistance point, it is at 1.1367.
Chimerix Inc [CMRX] reported earnings per share of -$0.2 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.24/share, meaning a difference of $0.04 and a surprise factor of 16.70%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.27 per share as compared to estimates of -$0.23 per share, a difference of -$0.04 representing a surprise of -17.40%.
Ratios To Look Out For
It is important to note that Chimerix Inc [NASDAQ:CMRX] has a current ratio of 10.25. As well, the Quick Ratio is 10.25, while the Cash Ratio is 1.5. Considering the valuation of this stock, the price to sales ratio is 295.51, the price to book ratio is 0.49.
Transactions by insiders
Recent insider trading involved Jakeman David, VP OF FINANCE AND ACCOUNTING, that happened on Feb 14 ’24 when 2660.0 shares were sold. CHIEF FINANCIAL OFFICER, LaSpaluto Michelle completed a deal on Feb 14 ’24 to sell 1940.0 shares. Meanwhile, PRESIDENT AND CEO Andriole Michael T. sold 1744.0 shares on Feb 14 ’24.
